Welcome to the RfB

This website provides all information concerning the accredited EQA schemes of the RfB:

News

The guideline Rili-BÄK is now available in English!

The Rili-BÄK is now available in the official translation of the German medical association.
Our survey program for 2025 is now online!

We are pleased to present our EQA schemes for 2025, including an extended programme.
Click here to go directly to the current programme.

Please note that some registration deadlines for early-starting EQA schemes in 2025 already end in 2024.
Call for Applications: Advanced Clinician Scientist (ACS) Program

The Stiftung für Pathobiochemie und Molekulare Diagnostik (SPMD) is pleased to announce the Advanced Clinician Scientist (ACS) Program. This unique special funding initiative supports outstanding medical research projects in the field of pathobiochemistry and molecular diagnostics.

The Stiftung für Pathobiochemie und Molekulare Diagnostik is providing up to €1.6 million in funding to support innovative projects that often cannot be realized due to a lack of time and financial resources.

For further information, please refer to the call for applications.
IgG subclass determination in IG4/24

Starting with the survey IG4/24 you have the possibility to perform the IgG subclass determination (IgG1, IgG2, IgG3, IgG4).
EurA1cTrial 2022

EurA1c, the trial exploring the effectiveness of HbA1c tests across various countries and manufacturers, was conducted for the seventh time in 2022. Over 4,000 laboratories in 22 countries participated. The report is now available on our website.

Office
Friesdorfer Straße 153
53175 Bonn

Phone: +49 2 28 / 92 68 95 - 0
Fax: +49 2 28 / 92 68 95 - 29

Internet: www.rfb.bio
E-mail: info@spmd-rfb.de

Download:
certificate of accreditation